+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adrenergic Antagonist"

Adrenergic Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenergic Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Adrenergic antagonists, also known as beta blockers, are a class of cardiovascular drugs used to treat hypertension, angina, and other heart conditions. They work by blocking the action of the sympathetic nervous system, which is responsible for the body's fight-or-flight response. Adrenergic antagonists can also be used to treat arrhythmias, migraines, and anxiety. They are generally well-tolerated and have few side effects. Adrenergic antagonists are widely used in the treatment of cardiovascular diseases, and are often prescribed in combination with other drugs. They are also used to reduce the risk of heart attack and stroke in people with high blood pressure or other risk factors. The market for adrenergic antagonists is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more